肿瘤细胞治疗研究
ALL SOURCES
A versatile self-amplifying mRNA system consolidates oncolytic virus benefits into a single flexible backbone for cancer therapy.
溶瘤病毒（OVs）代表了一种有前景的癌症免疫治疗手段；然而，其临床转化受到生产复杂性、生物安全问题、预存中和抗体以及病毒基因组工程限制的显著阻碍。
Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges.
癌症免疫治疗依赖于有效的抗原呈递和T细胞激活。
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.
基于过继转移T细胞或溶瘤病毒的抗肿瘤疗法近年来取得了显著进展，但其对实体瘤的浸润效率有限，单独使用时难以达到理想的抗肿瘤效果。
Nanomedicine for advanced cancer immunotherapy.
免疫治疗已成为一种强大的策略，用于治疗液体肿瘤，以克服传统癌症疗法的局限性。
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment.
癌症免疫疗法通过利用免疫系统特异性靶向癌细胞，彻底改变了肿瘤学领域，与传统疗法相比，其全身毒性更低。
New Standards in the Treatment of Advanced Metastatic Melanoma: Immunotherapy and BRAF-Targeted Therapies as Emerging Paradigms.
尽管皮肤黑色素瘤仅占皮肤癌的约 2%，但其快速进展使其成为一种高死亡率的侵袭性皮肤癌。
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landsc
黑色素瘤是一种侵袭性皮肤癌，治疗难度很大。
共 7 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
